Cell therapy and tissue engineering (TERCIT)

Meetings participation

  • Lyngstadaas, S.P.; Monjo, M.; Lamolle, S.F.; Rønold, H.J.; Ellingsen,J.E.. , "Expression of markers during bone healing and their significance in evaluating bone bonding and implant performance.". "AstraTech World Conference", New York, United States, 2006. Paper presentation.
  • Ellingsen, J.E.; Lyngstadaas, S.P.; Monjo, M.. , "Biological effects of fluoride-modifed titanium implants at the interface". "AstraTech World Conference", New York, United States, 2006. Paper presentation.
  • Lamolle, S.F.; Monjo, M.; Haugen, H.J.; Petzold, C.; Rønold, H.J.; Lyngstadaas, S.P.; Ellingsen, J.E.. , "Characterization and in vivo function of hydrofluoric acid modified titanium implants.". "20th European Conference on Biomaterials", Nantes, France, 2006. Poster.
  • Monjo, M.; Lyngstadaas, S.P.; Rønold, H.J.; Yousefi, S.; Ellingsen, J.E.. , "Fluoride-modified titanium implants enhance osteoblast differentiation both in vitro and in vivo.". "20th European Conference on Biomaterials", Nantes, France, 2006. Poster.
  • Monjo, M.; Lyngstadaas, S.P.; Rønold, H.J.; Yousefi, S.; Ellingsen, J.E.. , "Effect of fluoride-modified titanium implants on inflammation, bone formation and resorption markers at the interface.". "Bone Research Symposium", Oslo, Norway, 2006. Paper presentation.